The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mr I,
Just to preempt your conspiracy theory running wilder than normal,Iāll be going away again in about a week.
Thatās regardless of the SP movement, itās called living life, you should try it one day.
I suspect those in the dilution camp are expecting a much lower discount to SP than you state, time will tell.
AIMO
Mri,
āI would have thought anyone who believed this was a slam dunk from prevail or another pharma would be gobbling up these shares. ā
Why are you confused when youāve clearly answered your own question in the statement made earlier and copied above?
By definition, many do not believe itās a slam dunk and are concerned about a large funding dilution.
Ps.
Your MO is so transparent . Complain a little about the company for credibility and then suggest only a fool wouldnāt buy right now.
Youāve been applying the same old for years, iād suggest a change if you really want to influence š
AIMO
JFHā¦JFHā¦dear boy,
Please, READ the question!
We all know how shorts win or lose, thank you.
The question (still unanswered!!) ,
ā¦ WHY is there such a large short interest open?
Why do the shorterās believe the SP will fall when you, all but guarantee Funding will not be diluting?
Do you see my point yet? The big boys think youāre wrong.
AIMO
JFH,
Please try and be a little less verbose, lifeās to short to read your posts !
Anyway, ā¦was that an answer ? I donāt think so!
So again, to you & Stinky Pete,
Q, Why is there such a large short interest if as you and others propose , thereās a non dilutive funding deal/partnership around the corner of the O.K.Corral ?
Try again and please fewer words š
AIMO
HT , (Stinky Pete).
I like the analogy!
One question and one Iāve already asked JFH who refused an answer.
Q, Why is there such a large short interest if as you and others propose , thereās a non dilutive funding deal/partnership around the corner of the O.K.Corral ?
Looking forward to a plausible answer.
AIMO
JFH,
Last dig I promise, on anchor watch and need a drink!
Canāt stop myself from highlighting the exact words you used when last wrong regarding dilutive funding.
āItās incredibly unlikely ā ā¦and then it happened!
Good night.
AIMO
JFH,
Nope Vlad didnāt state what you claim and neither would he . The company knows better and would not blatantly mislead as you are & have.
Letās put this straight right now.
Hemoā have NOT stated within any RNS that they have a cure for all known viruses and/or cancer.
Yes they hope some of their products have such potential.
To state they already have cures as you have, is misleading and discredits you and your intelligence.
AIMO
JFH,
Why did you feel the need to state publicly that Hemo have a cure for all viruses and cancer, when actually they donāt!?
Why deliberately mislead ?
Iāve made my thoughts on funding clear and unless you can point it out for me , I believe Iāve told no untruths such as yours.
Letās leave it there.
Happy to eat humble pie should funding through P1 be none dilutive.
Weāll see.
AIMO
JFH,
We agree substantial fundingās required, the company have stated the same.
Where we strongly disagree is the type and reasons effecting itās ease of availability or otherwise.
Your argument (in writing), the company has a cure for all known viruses and cancer, (AML) I presume?
They donāt but letās run with you claims for argument sake.
So considering the above professional investors overlook investing and instead are making it very difficult to get the required funding by shorting the stock because they believeā¦what exactly ?
A very obtuse argument !
I on the other hand believe, Hemoā has an embryonic opportunity to try a Possible treatment for AML, a renowned and difficult arena for drug development.
Professional investors know how the odds are unfortunately stacked against the company and thatās why funding might be difficult to secure.
A bit more straight forward and obvious argument donāt you think!?
I suppose should a stinging dilutive funding hit present investors, youāll then blame those same shorters and conveniently step over the Elephant in the room,
ā¦ the reality of just where the company are on the path to those cures you claim and thatās definitely not where you state.
Stop blaming others for the difficulties, itās simply a function of the AML drug development arena Hemo have entered.
Please note my use of the word ā unfortunately ā .
Would any reasonable person really not want a successful treatment for AML .
AIMO
JFH,
Iām nervous! ā¦ take a look at your own posts!
āSubstantial funding will be required by the Company during the clinical trial phase and further funding will be sought by the Company prior to the commencement of the Phase I clinical trials.ā
The above a company statement .
So the only question is, will it be dilutive for present holders or not.
I maintain, history says it will.
Letās see.
AIMO
Ps. When did Hemoā develop a cure for cancer and all known viruses as you claim? I must have missed that RNS.
Chris,
Thatās the type of post that should be encouraged.
A witty and jovial expression of an alternate opinion and not the venomous attack I usually attract.
Maybe thatās because youāre not as desperate as some others, whicheverā¦nice postš
Mr I,
When a poster dare question the narrative the gang wish to promote, presently beingā¦
āthereās no chance of a diluting fund raiseā,
Use all the tricks in the book to discredit, ie he/she they are short, want to buy in lower, bury the post, change the thread ā¦and so on.
Iām afraid the gangs tactics are too obvious as is evident .
And just to remind you, who was it that correctly identified the risk of a CH and was harangued by the gang for doing so?
Same old !
Considering the information available,I believe thereās a significant risk of a large dilutive fund raise.
Letās see who turns out to be correct.
AIMO
Mr I,
āAt present the FUD spreaders still have the upper hand and are pushing out threats of placing. As JHFH as clearly said, that is highly unlikely ā
The market seems to disagree and letās not forget, what many LTHās here vehemently predicted āhighly unlikelyā in the past ā¦how did that turn out?
We know Hemoā have been presenting the opportunity at investor events as a fact.
Were the opportunity so obvious and the risk/reward so clearly skewed toward reward as you suggest, then wouldnāt a funding package of the type required already have been secured and announced!?
Letās be careful with predictions and learn the lesson of the miss leading and very costly to some, 95% days !
AIMO
Condoms,
Donāt mind answering even knowing youāre fishing to attack .
1. Greater than that apparent at a time in history when both the company and investors anticipated being clinical.
2.Yes, that is a āpossibleā scenario along with many more.
I prefer to invest on āProbableā scenarios and given the particular difficulties with AML trials & treatments, I doubt it probable.
3. I donāt see it unfolding at all until further funding .
It appears the market (SP, open shorts and selling) also has reservations that need attending before a re-rate and upwards correction in valuation .
Of course , anything is possible the above just my view others equally valid.
AIMO
HT,
A completely different animal that the market has now valued.
JFH may not like that valuation, it is however reality.
Funding sorted and phase1/2 positive, then heād be right in suggesting a re-rate required.
Until, just noise and wishful thinking.
AIMO